GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
C93.21
Subacute monocytic leukemia, in remission
ICD10CM code
Similar Codes
ICD10CM codes
C93.21
- Subacute monocytic leukemia, in remission
C93.01
- Acute monoblastic/monocytic leukemia, in remission
C93.71
- Other monocytic leukemia, in remission
C92.51
- Acute myelomonocytic leukemia, in remission
C93.Z1
- Other monocytic leukemia, in remission
C93.11
- Chronic myelomonocytic leukemia, in remission
C91.21
- Subacute lymphocytic leukemia, in remission
C93.91
- Monocytic leukemia, unspecified in remission
C95.21
- Subacute leukemia of unspecified cell type, in remission
C92.01
- Acute myeloblastic leukemia, in remission
HCPCS codes
G9396
- Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve m
P9058
- Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit
G9842
- Patient has metastatic disease at diagnosis
J9311
- Injection, rituximab 10 mg and hyaluronidase
C9467
- Injection, rituximab and hyaluronidase, 10 mg
J9312
- Injection, rituximab, 10 mg
P9053
- Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit
S0178
- Lomustine, oral, 10 mg
P9033
- Platelets, leukocytes reduced, irradiated, each unit
A9543
- Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
CPT4 codes
3092F
- Major depressive disorder, in remission (MDD)
85660
- Sickling of RBC, reduction
80193
- Leflunomide
78102
- Bone marrow imaging; limited area
38221
- Diagnostic bone marrow; biopsy(ies)
79403
- Radiopharmaceutical therapy, radiolabeled monoclonal antibody by intravenous infusion
86950
- Leukocyte transfusion
96406
- Chemotherapy administration; intralesional, more than 7 lesions
85097
- Bone marrow, smear interpretation
38242
- Allogeneic lymphocyte infusions